Sagimet Biosciences to Participate in Two Upcoming Investor Conferences – KTLA

SAN MATEO, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company …

Do you trust this headline?

Based on recent headline ratings, 100% of this readership currently trusts the local media, which has an average score of 86% regionally and is currently trending positivepositive.


Media Trust Score100%